Wall Street Analysts Forecast Growth Several research analysts recently issued reports on ACON shares. Ascendiant Capital Markets reduced their price target on shares of Aclarion from $502.50 to ...
BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...
ACON Investments ("ACON"), today announced the sale of its equity interests in Kept Companies, Inc. ("Kept" or the "Company") ...